Eli Lilly’s Obesity Drug, Tirzepatide, Fast Tracked In US; Rolling Submission To Start This Year
The FDA has granted Fast Track designation for Eli Lilly And Co’s (NYSE: LLY) tirzepatide for adults with obesity or overweight with weight-related…